MITCHELL C SHIRAH
- Type
- Physician · Allopathic & Osteopathic Physicians / Family Medicine
- Where
- ROANOKE, AL
- NPI
- 1902889371
- Received
- $2,380 in 108 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 10 | $287 |
| 2024 | General payment | 7 | $131 |
| 2023 | General payment | 18 | $303 |
| 2022 | General payment | 27 | $458 |
| 2021 | General payment | 25 | $699 |
| 2020 | General payment | 10 | $189 |
| 2019 | General payment | 11 | $309 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Novo Nordisk Inc | 65 | $1,471 | 2019–2025 |
| VIVUS LLC | 26 | $373 | 2019–2025 |
| Lilly USA, LLC | 7 | $320 | 2022–2025 |
| Currax Pharmaceuticals LLC | 7 | $100 | 2019–2022 |
| AstraZeneca Pharmaceuticals LP | 1 | $83 | 2019 |
| Janssen Pharmaceuticals, Inc | 1 | $15 | 2020 |
| Eisai Inc. | 1 | $15 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 108 | $2,380 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-11-12 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-08-20 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-07-18 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-06-25 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-06-17 | Novo Nordisk Inc | $47 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-05-15 | Lilly USA, LLC | $110 | Food and Beverage | Cash or cash equivalent | ZEPBOUND Drug, Obesity | 2025 | |
| 2025-05-14 | VIVUS LLC | $17 | Food and Beverage | In-kind items and services | PANCREAZE Drug, GASTROENTEROLOGY | 2025 | |
| 2025-05-08 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-02-12 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2025-01-15 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2025 | |
| 2024-12-05 | Novo Nordisk Inc | $19 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-10-30 | VIVUS LLC | $13 | Food and Beverage | In-kind items and services | PANCREAZE Drug, GASTROENTEROLOGY | 2024 | |
| 2024-10-23 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-07-10 | Lilly USA, LLC | $21 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-06-14 | Novo Nordisk Inc | $21 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2024 | |
| 2024-04-24 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-02-15 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2023-12-08 | Lilly USA, LLC | $16 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2023 | |
| 2023-12-08 | Novo Nordisk Inc | $9 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-10-18 | Novo Nordisk Inc | $12 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-10-04 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-09-21 | Lilly USA, LLC | $99 | Food and Beverage | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2023 | |
| 2023-09-06 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-08-23 | Novo Nordisk Inc | $8 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-08-09 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-07-28 | Novo Nordisk Inc | $9 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-07-14 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-06-30 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-05-31 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-05-19 | Novo Nordisk Inc | $9 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-05-05 | Novo Nordisk Inc | $13 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-03-23 | VIVUS LLC | $12 | Food and Beverage | In-kind items and services | QSYMIA Drug, ENDOCRINOLOGY | 2023 | |
| 2023-03-22 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-03-08 | Novo Nordisk Inc | $9 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2023-02-10 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2023 | |
| 2022-12-21 | VIVUS LLC | $11 | Food and Beverage | In-kind items and services | QSYMIA Drug, ENDOCRINOLOGY | 2022 | |
| 2022-12-12 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-11-21 | VIVUS LLC | $7 | Food and Beverage | In-kind items and services | QSYMIA Drug, ENDOCRINOLOGY | 2022 | |
| 2022-11-09 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-10-27 | VIVUS LLC | $15 | Food and Beverage | In-kind items and services | QSYMIA Drug, ENDOCRINOLOGY | 2022 | |
| 2022-10-18 | Novo Nordisk Inc | $85 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-09-28 | VIVUS LLC | $12 | Food and Beverage | In-kind items and services | QSYMIA Drug, ENDOCRINOLOGY | 2022 | |
| 2022-09-22 | Lilly USA, LLC | $36 | Food and Beverage | Cash or cash equivalent | MOUNJARO Drug, Diabetes | 2022 | |
| 2022-09-07 | Novo Nordisk Inc | $23 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-08-17 | VIVUS LLC | $11 | Food and Beverage | In-kind items and services | QSYMIA Drug, ENDOCRINOLOGY | 2022 | |
| 2022-08-10 | Novo Nordisk Inc | $23 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-07-29 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-07-13 | VIVUS LLC | $11 | Food and Beverage | In-kind items and services | QSYMIA Drug, ENDOCRINOLOGY | 2022 | |
| 2022-06-15 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-06-08 | Currax Pharmaceuticals LLC | $15 | Food and Beverage | In-kind items and services | CONTRAVE Drug, Obesity | 2022 | |
| 2022-06-01 | VIVUS LLC | $11 | Food and Beverage | In-kind items and services | QSYMIA Drug, ENDOCRINOLOGY | 2022 | |
| 2022-05-04 | VIVUS LLC | $15 | Food and Beverage | In-kind items and services | QSYMIA Drug, ENDOCRINOLOGY | 2022 | |
| 2022-04-27 | Novo Nordisk Inc | $21 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-04-13 | VIVUS LLC | $13 | Food and Beverage | In-kind items and services | QSYMIA Drug, ENDOCRINOLOGY | 2022 | |
| 2022-04-13 | Novo Nordisk Inc | $6 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-04-13 | Novo Nordisk Inc | $1 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-03-16 | Novo Nordisk Inc | $7 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-03-02 | Novo Nordisk Inc | $20 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-02-28 | Novo Nordisk Inc | $5 | Food and Beverage | In-kind items and services | Rybelsus Drug, Diabetes | 2022 | |
| 2022-02-23 | VIVUS LLC | $13 | Food and Beverage | In-kind items and services | QSYMIA Drug, ENDOCRINOLOGY | 2022 | |
| 2022-01-19 | Novo Nordisk Inc | $22 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2022 | |
| 2022-01-12 | VIVUS LLC | $13 | Food and Beverage | In-kind items and services | QSYMIA Drug, ENDOCRINOLOGY | 2022 | |
| 2021-12-15 | VIVUS LLC | $12 | Food and Beverage | In-kind items and services | Qsymia Drug, ENDOCRINOLOGY | 2021 | |
| 2021-12-01 | Novo Nordisk Inc | $16 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2021 | |
| 2021-11-17 | VIVUS LLC | $13 | Food and Beverage | In-kind items and services | Qsymia Drug, ENDOCRINOLOGY | 2021 | |
| 2021-11-04 | Novo Nordisk Inc | $103 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2021 | |
| 2021-10-27 | VIVUS LLC | $21 | Food and Beverage | In-kind items and services | Qsymia Drug, ENDOCRINOLOGY | 2021 | |
| 2021-10-20 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2021 | |
| 2021-09-22 | Novo Nordisk Inc | $14 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2021 | |
| 2021-09-08 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2021 | |
| 2021-08-25 | VIVUS LLC | $18 | Food and Beverage | In-kind items and services | Qsymia Drug, ENDOCRINOLOGY | 2021 | |
| 2021-08-12 | Novo Nordisk Inc | $91 | Food and Beverage | In-kind items and services | RYBELSUS Drug, Diabetes | 2021 | |
| 2021-08-11 | Novo Nordisk Inc | $17 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2021 | |
| 2021-07-28 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2021 | |
| 2021-07-14 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Wegovy Drug, Obesity | 2021 | |
| 2021-05-26 | VIVUS LLC | $22 | Food and Beverage | In-kind items and services | Qsymia Drug, ENDOCRINOLOGY | 2021 | |
| 2021-05-20 | Novo Nordisk Inc | $88 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2021 | |
| 2021-05-13 | Novo Nordisk Inc | $112 | Food and Beverage | In-kind items and services | RYBELSUS Drug, Diabetes | 2021 | |
| 2021-05-05 | Novo Nordisk Inc | $8 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2021 | |
| 2021-04-28 | VIVUS LLC | $21 | Food and Beverage | In-kind items and services | Qsymia Drug, ENDOCRINOLOGY | 2021 | |
| 2021-04-07 | VIVUS LLC | $11 | Food and Beverage | In-kind items and services | Qsymia Drug, ENDOCRINOLOGY | 2021 | |
| 2021-03-03 | Novo Nordisk Inc | $12 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2021 | |
| 2021-02-24 | VIVUS LLC | $17 | Food and Beverage | In-kind items and services | Qsymia Drug, ENDOCRINOLOGY | 2021 | |
| 2021-02-10 | VIVUS LLC | $10 | Food and Beverage | In-kind items and services | Qsymia Drug, ENDOCRINOLOGY | 2021 | |
| 2021-02-03 | Currax Pharmaceuticals LLC | $14 | Food and Beverage | In-kind items and services | CONTRAVE Drug, OBESITY | 2021 | |
| 2021-01-27 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2021 | |
| 2021-01-13 | Novo Nordisk Inc | $15 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2021 | |
| 2020-12-09 | Novo Nordisk Inc | $12 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2020 | |
| 2020-12-02 | Currax Pharmaceuticals LLC | $15 | Food and Beverage | In-kind items and services | CONTRAVE Drug, OBESITY | 2020 | |
| 2020-11-18 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2020 | |
| 2020-10-22 | Novo Nordisk Inc | $9 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2020 | |
| 2020-09-24 | Novo Nordisk Inc | $83 | Food and Beverage | In-kind items and services | RYBELSUS Drug, Diabetes | 2020 | |
| 2020-08-26 | Currax Pharmaceuticals LLC | $14 | Food and Beverage | In-kind items and services | CONTRAVE Drug, OBESITY | 2020 | |
| 2020-08-11 | Novo Nordisk Inc | $6 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2020 | |
| 2020-07-22 | Currax Pharmaceuticals LLC | $11 | Food and Beverage | In-kind items and services | CONTRAVE Drug, OBESITY | 2020 | |
| 2020-04-21 | Janssen Pharmaceuticals, Inc | $15 | Food and Beverage | In-kind items and services | XARELTO Drug, Cardiovascular & Metabolism | 2020 | |
| 2020-03-04 | Novo Nordisk Inc | $11 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2020 | |
| 2019-12-18 | Currax Pharmaceuticals LLC | $13 | Food and Beverage | In-kind items and services | CONTRAVE Drug, OBESITY | 2019 | |
| 2019-12-13 | VIVUS LLC | $13 | Food and Beverage | In-kind items and services | QSYMIA Drug, ENDOCRINOLOGY | 2019 | |
| 2019-11-27 | Currax Pharmaceuticals LLC | $15 | Food and Beverage | In-kind items and services | CONTRAVE Drug, OBESITY | 2019 | |
| 2019-11-05 | AstraZeneca Pharmaceuticals LP | $83 | Food and Beverage | In-kind items and services | XIGDUO Drug, Cardiovascular and Metabolism | 2019 | |
| 2019-10-16 | VIVUS LLC | $17 | Food and Beverage | In-kind items and services | QSYMIA Drug, ENDOCRINOLOGY | 2019 | |
| 2019-10-02 | Novo Nordisk Inc | $10 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2019 | |
| 2019-08-01 | Novo Nordisk Inc | $9 | Food and Beverage | In-kind items and services | Ozempic Drug, Diabetes | 2019 | |
| 2019-06-11 | Novo Nordisk Inc | $76 | Food and Beverage | In-kind items and services | Saxenda Drug, Obesity | 2019 | |
| 2019-05-01 | Eisai Inc. | $15 | Food and Beverage | Cash or cash equivalent | Belviq Drug, Nutrition and Weight Loss | 2019 | |
| 2019-03-06 | VIVUS LLC | $11 | Food and Beverage | In-kind items and services | QSYMIA Drug, ENDOCRINOLOGY | 2019 | |
| 2019-02-19 | Novo Nordisk Inc | $42 | Food and Beverage | In-kind items and services | Tresiba Drug, Diabetes | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Roanoke, AL, county Randolph County, AL, state Alabama; placed by its city name.
| Measure | Place (city or town) Roanoke, AL | County Randolph County, AL | State Alabama |
|---|---|---|---|
| Population B01003 | 5,336 | 22,510 | 5,086,768 |
| Population, 2020 census P1 | 5,311 | 21,967 | 5,024,279 |
| Median age B01002 | 42.5 | 43.4 | 39.3 |
| Under 18 B01001 | 24.0% | 20.9% | 22.2% |
| 65 and over B01001 | 24.3% | 21.9% | 17.8% |
| Households B11001 | 2,344 | 9,271 | 1,997,247 |
| Foreign born B05002 | 1.5% | 1.4% | 4.0% |
| Median household income B19013 | $47,105 | $52,338 | $63,999 |
| Median family income B19113 | $64,158 | $70,011 | $83,032 |
| Per capita income B19301 | $28,471 | $30,082 | $36,087 |
| Poverty rate B17001 | 12.5% | 19.9% | 15.6% |
| Unemployment rate B23025 | 3.4% | 3.8% | 4.7% |
| Civilian labor force B23025 | 2,233 | 9,333 | 2,367,787 |
| Mean commute (minutes) B08013 | 21.6 | 28.9 | 25.5 |
| Bachelor's degree or higher B15003 | 17.0% | 18.4% | 28.4% |
| Housing units B25001 | 2,860 | 12,505 | 2,337,265 |
| Owner-occupied B25003 | 67.2% | 77.2% | 70.2% |
| Renters B25003 | 32.8% | 22.8% | 29.8% |
| Median home value B25077 | $154,300 | $181,600 | $209,900 |
| Median gross rent B25064 | $666 | $708 | $1,007 |
| White, not Hispanic B03002 | 57.4% | 74.6% | 63.4% |
| Black B03002 | 39.9% | 15.5% | 25.6% |
| Hispanic or Latino B03002 | 1.5% | 3.0% | 5.6% |
| Asian B03002 | 0.1% | 0.4% | 1.4% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.3% |
Economy now FRED unemployment 3.5% in Sep 2026 (2.8% a year earlier); per capita personal income $59,754 in 2025, up 30% in five years (+4.7% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Roanoke, AL.
Comments